  See all
 |
Articles: Drug/Product Approvals |
Prior Articles
Amylin Issues Statement in Response to Carl Icahn
Amylin Pharmaceuticals, 04/27/09
Free full text
FDA Approves Monthly Injectable Drug for Treating Three Types of Immune-Related Arthritis
FDA Press Releases, 04/27/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 04/27/09
Free full text
U.S. Food and Drug Administration Extends Review Timeline for ONGLYZA (saxagliptin) New Drug Application
Bristol Myers-Squibb Company, 04/24/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 04/24/09
Free full text
Elan and Transition Therapeutics Receive Key Patent for Alzheimers Disease Treatment with ELND005
Elan, 04/24/09
Free full text
Cytokinetics Announces Non-clinical Data Relating to GSK-923295 Presented at the 2009 American Association of Cancer Research Annual Meeting
Cytokinetics, 04/23/09
Free full text
FDA Researchers Contribute Insights into Avian Flu Virus
FDA Press Releases, 04/22/09
Free full text
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Forest Laboratories, 04/21/09
Free full text
Myriad Genetics, Inc. Receives Approval From New York Stock Exchange to Proceed With New Listing
Myriad, 04/16/09
Free full text
Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
Cell Therapeutics, 04/15/09
Free full text
Myriad Pharmaceuticals Receives IND Approval for New Cancer Drug
Myriad, 04/15/09
Free full text
Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
Myriad, 04/15/09
Free full text
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda Cancer Treatment
Mylan, 04/15/09 Desvenlafaxine: a new antidepressant or just another one
Expert Opinion in Pharmacotherapy, 04/14/09 Budesonide/Formoterol (Symbicort): Corticosteroid/LABA combination approved for the maintenance treatment of COPD
Formulary, 04/10/09 FDA Advisory Committee recommendation on SEROQUEL XR Supplemental New Drug Applications
AstraZeneca, 04/09/09
Free full text
FDA Approves Coartem Tablets to Treat Malaria
FDA Press Releases, 04/09/09
Free full text
Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US
Novartis, 04/09/09
Free full text
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Watson Pharmaceuticals, 04/08/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
